NYSE:AVNS Avanos Medical (AVNS) Stock Price, News & Analysis $12.35 -0.03 (-0.24%) As of 07/3/2025 03:30 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Avanos Medical Stock (NYSE:AVNS) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Avanos Medical alerts:Sign Up Key Stats Today's Range$12.23▼$12.4750-Day Range$12.05▼$13.1252-Week Range$11.75▼$25.36Volume144,217 shsAverage Volume382,361 shsMarket Capitalization$571.06 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Avanos Medical, Inc., a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides a portfolio of non-opioid pain solutions, including surgical pain and recovery products, such as ON-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy; OrthogenRx's knee osteoarthritis hyaluronic acid pain relief injection products; and Trident radiofrequency ablation products to treat chronic pain conditions. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia. Read More Receive AVNS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Avanos Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address AVNS Stock News HeadlinesElanco Animal Health Earns RS Rating UpgradeJune 23, 2025 | msn.comAvanos Medical, Inc. Welcomes Camille Chang Gilmore as Senior Vice President and Chief Human ...June 9, 2025 | gurufocus.comThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.July 4 at 2:00 AM | Brownstone Research (Ad)Avanos Medical, Inc. Welcomes Camille Chang Gilmore as Senior Vice President and Chief Human ...June 9, 2025 | gurufocus.comAvanos Medical, Inc. Welcomes Camille Chang Gilmore as Senior Vice President and Chief Human Resources OfficerJune 9, 2025 | prnewswire.comQ1 2025 Avanos Medical Inc Earnings CallMay 7, 2025 | uk.finance.yahoo.comAvanos Medical (AVNS): Positioned for Growth Under New LeadershipMay 7, 2025 | msn.comAvanos Medical Inc (AVNS) Q1 2025 Earnings Call Highlights: Strong Start with Challenges AheadMay 7, 2025 | finance.yahoo.comSee More Headlines AVNS Stock Analysis - Frequently Asked Questions How have AVNS shares performed this year? AVANOS MEDICAL's stock was trading at $15.92 on January 1st, 2025. Since then, AVNS shares have decreased by 22.4% and is now trading at $12.35. How were AVANOS MEDICAL's earnings last quarter? AVANOS MEDICAL, INC. (NYSE:AVNS) released its quarterly earnings results on Tuesday, May, 6th. The company reported $0.26 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.19 by $0.07. The firm's quarterly revenue was up .8% on a year-over-year basis. Read the conference call transcript. How do I buy shares of AVANOS MEDICAL? Shares of AVNS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of AVANOS MEDICAL own? Based on aggregate information from My MarketBeat watchlists, some other companies that AVANOS MEDICAL investors own include JPMorgan Chase & Co. (JPM), Meta Platforms (META), NVIDIA (NVDA), Advanced Micro Devices (AMD), Home Depot (HD), Netflix (NFLX) and Tesla (TSLA). Company Calendar Last Earnings5/06/2025Today7/04/2025Next Earnings (Estimated)7/30/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry MED INSTRUMENTS Sub-IndustryMedical Equipment Current SymbolNYSE:AVNS CIK1606498 Webavanos.com Phone(844) 428-2667FaxN/AEmployees2,227Year FoundedN/AProfitability EPS (Trailing Twelve Months)($8.37) Trailing P/E RatioN/A Forward P/E Ratio9.36 P/E GrowthN/ANet Income-$392.10 million Net Margins-55.80% Pretax Margin-57.33% Return on Equity6.26% Return on Assets4.63% Debt Debt-to-Equity Ratio0.12 Current Ratio2.57 Quick Ratio1.56 Sales & Book Value Annual Sales$687.80 million Price / Sales0.83 Cash Flow$11.88 per share Price / Cash Flow1.04 Book Value$18.03 per share Price / Book0.68Miscellaneous Outstanding Shares46,240,000Free Float45,023,000Market Cap$571.06 million OptionableOptionable Beta1.12 The Best Nuclear Energy Stocks to BuyNuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.Get This Free Report This page (NYSE:AVNS) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersElon’s RevengeElon Musk and President Trump's new feud is all over the news... But what no one has reported – yet – is th...Altimetry | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredGold: Now legal tender in many statesThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avanos Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avanos Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.